EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $33.86 Consensus Price Target from Brokerages

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock […]

Related Keywords

Darioa Paggiarino , ,Analyst Recommendations For Eyepoint Pharmaceuticals ,News Ratings For Eyepoint Pharmaceuticals Daily ,Franklin Resources Inc ,Securities Exchange Commission ,Vanguard Group Inc ,Jpmorgan Chase Co ,Eyepoint Pharmaceuticals ,Eyepoint Pharmaceuticals Inc ,Pricet Rowe Associates Inc ,Eyepoint Pharmaceuticals Price Performance ,Jennison Associates ,Nasdaq ,Get Free Report ,One Financial ,Cormorant Asset Management ,Exchange Commission ,Asset Management ,Franklin Resources ,Point Pharmaceuticals ,Get Free ,Eyepoint Pharmaceuticals Daily ,